Learning Center

 

How to search for specific webinars by categories:

  1. Select the "Search by Category" bar and unselect webinar
  2. Choose which categories of webinars you want included in the search
Search by Category
Search by Format
Search by Type
Sort By
Search by Favorites
  • Contains 5 Component(s)

    WEBINAR DESCRIPTION: In October 2023, the FDA issued a guidance document on Voluntary Consensus Standards Recognition Program for Regenerative Medicine Therapies. This guidance describes a standards recognition program for regenerative medicine therapies (SRP-RMT) at FDA’s Center for Biologics Evaluation and Research (CBER) designed to identify and recognize Voluntary Consensus Standards (VCS) to facilitate the development and assessment of regenerative medicine therapy (RMT) products regulated by CBER when such standards are appropriate. Standardization bodies such as Standards Coordinating Body (SCB) and the American National Standards Institute (ANSI) have helped to introduce and facilitate the VCS process, however, many stakeholders are unclear about the process. This webinar will discuss the VCS process, what the stakeholders need to know, and how to develop one. A case study of an actual international consensus standard development of tissue-specific MSC biobanking, characterization, terminology with extensive and iterative input from ISCT will also be presented.

    • Register
      • Member - Free!
      • Advanced Practice Professional Member - Free!
      • Complimentary Member - Free!
      • Industry Community - Free!
      • Industry Community Sub Account - Free!
      • Laboratory Member - Free!
      • Laboratory Technologist Sub Account - Free!
      • Laboratory Regular Member Sub Account - Free!
      • Laboratory Resident and Fellow Sub Account - Free!
      • Regular Member - Free!
      • Resident or Fellow Member - Free!
      • Student Member - Free!
      • Technologist Member - Free!
    • More Information
  • Contains 5 Component(s)

    WEBINAR DESCRIPTION: In October 2023, the FDA issued a guidance document on Voluntary Consensus Standards Recognition Program for Regenerative Medicine Therapies. This guidance describes a standards recognition program for regenerative medicine therapies (SRP-RMT) at FDA’s Center for Biologics Evaluation and Research (CBER) designed to identify and recognize Voluntary Consensus Standards (VCS) to facilitate the development and assessment of regenerative medicine therapy (RMT) products regulated by CBER when such standards are appropriate. Standardization bodies such as Standards Coordinating Body (SCB) and the American National Standards Institute (ANSI) have helped to introduce and facilitate the VCS process, however, many stakeholders are unclear about the process. This webinar will discuss the VCS process, what the stakeholders need to know, and how to develop one. A case study of an actual international consensus standard development of tissue-specific MSC biobanking, characterization, terminology with extensive and iterative input from ISCT will also be presented.

    • Register
      • Member - Free!
      • Advanced Practice Professional Member - Free!
      • Complimentary Member - Free!
      • Industry Community - Free!
      • Industry Community Sub Account - Free!
      • Laboratory Member - Free!
      • Laboratory Technologist Sub Account - Free!
      • Laboratory Regular Member Sub Account - Free!
      • Laboratory Resident and Fellow Sub Account - Free!
      • Regular Member - Free!
      • Resident or Fellow Member - Free!
      • Student Member - Free!
      • Technologist Member - Free!
    • More Information
  • Contains 5 Component(s)

    WEBINAR DESCRIPTION: Join us for a deep dive into the world of CAR-T cell therapy development with our webinar titled "Navigating CAR-T Cell Therapy Development: Insights from Leading SCA Academic Centers." Organized by the ISCT South & Central America (SCA) Regional Executive Committee and the South and Central America (SCA) Regional ESP Subcommittee. The event will be co-chaired by Samuel Couto and Lilia León Moreno. The webinar will open with Virginia Picanço-Castro sharing her experience from one of Brazil's leading institutes on the complete developmental journey of a CAR-T cell product, from bench to bedside. She will provide a detailed overview of the unique manufacturing challenges faced and the innovative strategies implemented to bring CAR-T cell therapies to clinical practice in Brazil. Andres Gomez will offer valuable insights from Mexico, discussing the development and implementation of CAR-T cell therapies within the local academic and clinical landscape. He will highlight the regulatory environment and the steps required to advance this novel treatment in Mexico. Chase Mccann will conclude the session by discussing the role of clinical trials in the development of CAR-T cell therapies, drawing from his experience at Children's National Hospital. He will focus on the latest advancements in pediatric applications and share real-world insights from ongoing clinical trials. This exclusive event offers members of the International Society for Cell & Gene Therapy (ISCT) an opportunity to explore the diverse paths of CAR-T therapy development across the South & Central America region. Engage with leading experts and discover the future of CAR-T therapy, from clinical trials to regulatory challenges and beyond.

    • Register
      • Member - Free!
      • Advanced Practice Professional Member - Free!
      • Complimentary Member - Free!
      • Industry Community - Free!
      • Industry Community Sub Account - Free!
      • Laboratory Member - Free!
      • Laboratory Technologist Sub Account - Free!
      • Laboratory Regular Member Sub Account - Free!
      • Laboratory Resident and Fellow Sub Account - Free!
      • Regular Member - Free!
      • Resident or Fellow Member - Free!
      • Student Member - Free!
      • Technologist Member - Free!
    • More Information
  • Contains 5 Component(s)

    WEBINAR DESCRIPTION: While an increasing number of regulatory approvals in the Cell and Gene Therapy (CGT) field has fueled optimism for potential treatments and cures for debilitating and fatal conditions, constant challenges to US FDA oversight – by courts, federal and state legislatures, and rogue “stem cell clinics” - pose serious risks for individual patients and for the entire industry. This webinar begins with an overview of the U.S. legal landscape governing development and therapeutic usage of stem cell and gene therapies, including several recent, highly-consequential court rulings impacting the FDA and other federal agencies. The webinar then addresses recent state developments that have attracted little public attention, including new iterations of “Right-To-Try” and “Medical Freedom” laws, and their legal and practical impact on experimental stem cell and gene therapies. After exploring the wide-spread availability of unproven stem cell and regenerative interventions currently being offered by stem cell clinics and in other unregulated settings, the webinar will highlight existing risks for individual patients and the entire CGT sector, and ways these may be further exacerbated in the near future. The area of unproven stem cell and regenerative medicine clinics will be discussed in more depth as an exemplar of complex legal, policy and ethical challenges to federal and state regulators. The webinar will conclude with an interactive panel discussion and an open Q&A for attendees to raise issues and contribute to the discussion.

    • Register
      • Non-member - Free!
      • Member - Free!
      • Advanced Practice Professional Member - Free!
      • Complimentary Member - Free!
      • Industry Community - Free!
      • Industry Community Sub Account - Free!
      • Laboratory Member - Free!
      • Laboratory Technologist Sub Account - Free!
      • Laboratory Regular Member Sub Account - Free!
      • Laboratory Resident and Fellow Sub Account - Free!
      • Regular Member - Free!
      • Resident or Fellow Member - Free!
      • Student Member - Free!
      • Technologist Member - Free!
    • More Information
  • Contains 3 Component(s)

    In Conversation with Asia CGT Startups

    • Register
      • Member - Free!
      • Advanced Practice Professional Member - Free!
      • Complimentary Member - Free!
      • Industry Community - Free!
      • Industry Community Sub Account - Free!
      • Laboratory Member - Free!
      • Laboratory Technologist Sub Account - Free!
      • Laboratory Regular Member Sub Account - Free!
      • Laboratory Resident and Fellow Sub Account - Free!
      • Regular Member - Free!
      • Resident or Fellow Member - Free!
      • Student Member - Free!
      • Technologist Member - Free!
    • More Information
  • Contains 3 Component(s)

    In Conversation with CGT Leaders

    • Register
      • Member - Free!
      • Advanced Practice Professional Member - Free!
      • Complimentary Member - Free!
      • Industry Community - Free!
      • Industry Community Sub Account - Free!
      • Laboratory Member - Free!
      • Laboratory Technologist Sub Account - Free!
      • Laboratory Regular Member Sub Account - Free!
      • Laboratory Resident and Fellow Sub Account - Free!
      • Regular Member - Free!
      • Resident or Fellow Member - Free!
      • Student Member - Free!
      • Technologist Member - Free!
    • More Information
  • Contains 3 Component(s)

    Hemophilia is an inherited bleeding disorder characterized by the deficiency or absence of clotting factors VIII (Hemophilia A) or IX (Hemophilia B). This lack of clotting factors leads to uncontrolled bleeding, which can result in severe health issues, particularly in the joints and brain. Despite significant advances in preventing bleeding episodes and managing the disease through prophylaxis and non-factor products, several needs remain unmet. One critical issue is the lack of a cure for the disease. This challenge is being strategically addressed through the development of innovative cell and gene therapies. The objective of this webinar, led by two eminent researchers, Dr. Edward Tuddenham (UK) and Dr. Blair Gage (Canada), is to discuss the latest advances and challenges associated with the use use of both therapies in treating Hemophilia A and B. Their goal is to achieve a durable reduction in both bleeding risks and the need for exogenous factor administrations.

    • Register
      • Member - Free!
      • Advanced Practice Professional Member - Free!
      • Complimentary Member - Free!
      • Industry Community - Free!
      • Industry Community Sub Account - Free!
      • Laboratory Member - Free!
      • Laboratory Technologist Sub Account - Free!
      • Laboratory Regular Member Sub Account - Free!
      • Laboratory Resident and Fellow Sub Account - Free!
      • Regular Member - Free!
      • Resident or Fellow Member - Free!
      • Student Member - Free!
      • Technologist Member - Free!
    • More Information
  • Contains 3 Component(s)

    Join us for an interactive workshop and Q&A led by global CGT recruiters who will provide insights on how to land your dream job and craft a path to elevate your career.

    • Register
      • Member - Free!
      • Advanced Practice Professional Member - Free!
      • Complimentary Member - Free!
      • Industry Community - Free!
      • Industry Community Sub Account - Free!
      • Laboratory Member - Free!
      • Laboratory Technologist Sub Account - Free!
      • Laboratory Regular Member Sub Account - Free!
      • Laboratory Resident and Fellow Sub Account - Free!
      • Regular Member - Free!
      • Resident or Fellow Member - Free!
      • Student Member - Free!
      • Technologist Member - Free!
    • More Information
  • Contains 3 Component(s)

    This webinar is an informed discussion around the current realities and challenges of cell and gene therapies for sickle cell disease with panelists from various roles/viewpoints in the field.

    • Register
      • Member - Free!
      • Advanced Practice Professional Member - Free!
      • Complimentary Member - Free!
      • Industry Community - Free!
      • Industry Community Sub Account - Free!
      • Laboratory Member - Free!
      • Laboratory Technologist Sub Account - Free!
      • Laboratory Regular Member Sub Account - Free!
      • Laboratory Resident and Fellow Sub Account - Free!
      • Regular Member - Free!
      • Resident or Fellow Member - Free!
      • Student Member - Free!
      • Technologist Member - Free!
    • More Information
  • Contains 2 Component(s)

    Join us for an engaging webinar where we explore the art of crafting and delivering impactful elevator pitch presentations. Discover proven strategies and techniques to captivate your audience and leave a lasting impression when showcasing your innovative research. Our speakers, including previous elevator pitch judges and winners, will share invaluable insights on composing your pitch, refining your message, and mastering delivery techniques to confidently showcase your ideas. Plus, you'll have dedicated exercise time to practice and receive feedback on your pitch. Whether you're a seasoned professional or just starting out, this webinar will equip you with the skills and confidence to make every elevator pitch count. Don't miss out – register now and elevate your presentation game!

    • Register
      • Member - Free!
      • Advanced Practice Professional Member - Free!
      • Complimentary Member - Free!
      • Industry Community - Free!
      • Industry Community Sub Account - Free!
      • Laboratory Member - Free!
      • Laboratory Technologist Sub Account - Free!
      • Laboratory Regular Member Sub Account - Free!
      • Laboratory Resident and Fellow Sub Account - Free!
      • Regular Member - Free!
      • Resident or Fellow Member - Free!
      • Student Member - Free!
      • Technologist Member - Free!
    • More Information